0.6(top 50%)
impact factor
594(top 50%)
papers
2.6K(top 50%)
citations
23(top 20%)
h-index
0.6(top 50%)
impact factor
871
all documents
2.8K
doc citations
36(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Evaluation of aquaporin‐4 antibody assaysClinical and Experimental Neuroimmunology2014106
2Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating diseaseClinical and Experimental Neuroimmunology201279
3T cell migration into the central nervous system during health and disease: Different molecular keys allow access to different central nervous system compartmentsClinical and Experimental Neuroimmunology201078
4Neuroinflammation in mouse models of Alzheimer's diseaseClinical and Experimental Neuroimmunology201877
5Japanese clinical guidelines for myasthenia gravis: Putting into practiceClinical and Experimental Neuroimmunology201563
6Neurotoxicity by microglia: Mechanisms and potential therapeutic strategyClinical and Experimental Neuroimmunology201062
7Microglia communication: Parallels between aging and Alzheimer's diseaseClinical and Experimental Neuroimmunology201660
8Neuron–astrocyte interactions in neurodegenerative diseases: Role of neuroinflammationClinical and Experimental Neuroimmunology201544
9Helicobacter pylori and gut microbiota in multiple sclerosis versus Alzheimer's disease: 10 pitfalls of microbiome studiesClinical and Experimental Neuroimmunology201743
10Neuroinflammation in motor neuron diseaseClinical and Experimental Neuroimmunology201641
11Neurological safety of fingolimod: An updated reviewClinical and Experimental Neuroimmunology201740
12Bevacizumab is safe in acute relapses of neuromyelitis opticaClinical and Experimental Neuroimmunology201539
13Neuro‐COVID‐19Clinical and Experimental Neuroimmunology202238
14What drives disease in multiple sclerosis: Inflammation or neurodegeneration?Clinical and Experimental Neuroimmunology201036
15Optic neuritis after COVID‐19 vaccine applicationClinical and Experimental Neuroimmunology202235
16Reactive astrocytes and perivascular macrophages express NLRP3 inflammasome in active demyelinating lesions of multiple sclerosis and necrotic lesions of neuromyelitis optica and cerebral infarctionClinical and Experimental Neuroimmunology201329
17Phenotypic heterogeneity of astrocytes in motor neuron diseaseClinical and Experimental Neuroimmunology201829
18Stable human brain microvascular endothelial cell line retaining its barrier‐specific nature independent of the passage numberClinical and Experimental Neuroimmunology201326
19Lymphatic system and gut microbiota affect immunopathology of neuroinflammatory diseases, including multiple sclerosis, neuromyelitis optica and Alzheimer's diseaseClinical and Experimental Neuroimmunology201726
20Prevalence and characteristics of transverse myelitis and neuromyelitis optica spectrum disorders in the United Arab Emirates: A multicenter, retrospective studyClinical and Experimental Neuroimmunology201826
21Chronic inflammatory demyelinating polyneuropathy: Clinical subtypes and their correlation with electrophysiologyClinical and Experimental Neuroimmunology201125
22Role of CCR2 in immunobiology and neurobiologyClinical and Experimental Neuroimmunology201225
23Role of antiproliferative gene Tob1 in the immune systemClinical and Experimental Neuroimmunology201424
24Clinical features and treatment status of adult myasthenia gravis in JapanClinical and Experimental Neuroimmunology201424
25Active form of vitamin D directly protects the blood–brain barrier in multiple sclerosisClinical and Experimental Neuroimmunology201724
26Role of the thymus in autoimmune myasthenia gravisClinical and Experimental Neuroimmunology201623
27Dysregulated T cells in multiple sclerosisClinical and Experimental Neuroimmunology201823
28Roles of glial cells in neuroinflammation and neurodegenerationClinical and Experimental Neuroimmunology201322
29Mind over cytokines: Crosstalk and regulation between the neuroendocrine and immune systemsClinical and Experimental Neuroimmunology201221
30Establishment and characterization of spinal cord microvascular endothelial cell linesClinical and Experimental Neuroimmunology201320
31Prevalence, treatments and medical cost of multiple sclerosis in Japan based on analysis of a health insurance claims databaseClinical and Experimental Neuroimmunology201720
32Anatomy and roles of lymphatics in inflammatory diseasesClinical and Experimental Neuroimmunology201720
33Effects of prolonged treatment with memantine in the MRL model of central nervous system lupusClinical and Experimental Neuroimmunology201219
34Regulatory T cells in multiple sclerosisClinical and Experimental Neuroimmunology202019
35Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes (Crow–Fukase) syndrome: Diagnostic criteria and treatment perspectivesClinical and Experimental Neuroimmunology201318
36Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin‐4 channelopathiesClinical and Experimental Neuroimmunology201418
37Connexins in health and diseaseClinical and Experimental Neuroimmunology201818
38Guillain–Barré syndrome after coronavirus disease 2019 vaccine: A temporal associationClinical and Experimental Neuroimmunology202218
39Immune response after striatal engraftment of fetal neuronal cells in patients with Huntington’s disease: Consequences for cerebral transplantation programsClinical and Experimental Neuroimmunology201117
40New diagnostic criteria could distinguish common variable immunodeficiency disorder from anticonvulsant‐induced hypogammaglobulinemiaClinical and Experimental Neuroimmunology201517
41Bioinformatics approach to identifying molecular biomarkers and networks in multiple sclerosisClinical and Experimental Neuroimmunology201015
42Three immune‐mediated disease models induced by Theiler's virus: Multiple sclerosis, seizures and myocarditisClinical and Experimental Neuroimmunology201615
43Drug‐induced progressive multifocal leukoencephalopathy in multiple sclerosis: A comprehensive reviewClinical and Experimental Neuroimmunology201815
44Neuron–microglia interactions in neuroinflammationClinical and Experimental Neuroimmunology201514
45Current treatment status and medical cost for multiple sclerosis based on analysis of a Japanese claims databaseClinical and Experimental Neuroimmunology201614
46Novel roles of oligodendrocyte precursor cells in the developing and damaged brainClinical and Experimental Neuroimmunology201714
47Pathogenesis of Theiler’s murine encephalomyelitis virus‐induced diseaseClinical and Experimental Neuroimmunology201013
48Myelin oligodendrocyte glycoprotein immunoglobulin G‐associated disease: An overviewClinical and Experimental Neuroimmunology201813
49Gene expression profiles of M1 and M2 microglia characterized by comparative analysis of public datasetsClinical and Experimental Neuroimmunology201813
50Pathogenic roles of antiganglioside antibodies in immune‐mediated neuropathiesClinical and Experimental Neuroimmunology201312